Natco Pharma's profit takes a hit, but new moves are in play

Business Nov 15, 2025

Natco Pharma saw its profits drop 23.44% this quarter, landing at ₹517.9 crore—mostly thanks to higher research costs and a one-time staff bonus.
Even so, total revenue nudged up to ₹1,463 crore, though actual sales stayed pretty much flat.

What's happening behind the numbers?

Exports dipped a bit, but Natco's homegrown business and crop health segment actually grew—crop health revenue jumped from ₹14.1 crore to ₹52.4 crore in just a year.
The extra spending on R&D and bonuses explains most of the profit slide.

What's next for Natco?

Natco is splitting off its Crop Health Sciences Division into its own company.
Plus, shareholders get an interim dividend of ₹1.50 per share as a small win during this bumpy quarter.